154 related articles for article (PubMed ID: 30601107)
1. Serum hCG threshold to assess medical abortion success.
Le Lous M; Gallinand AC; Laviolle B; Peltier L; Nyangoh Timoh K; Lavoué V
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):458-463. PubMed ID: 30601107
[TBL] [Abstract][Full Text] [Related]
2. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
[TBL] [Abstract][Full Text] [Related]
3. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208
[TBL] [Abstract][Full Text] [Related]
4. Early serum human chorionic gonadotropin (hCG) trends after medication abortion.
Pocius KD; Maurer R; Fortin J; Goldberg AB; Bartz D
Contraception; 2015 Jun; 91(6):503-6. PubMed ID: 25765358
[TBL] [Abstract][Full Text] [Related]
5. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164
[TBL] [Abstract][Full Text] [Related]
6. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.
Fiala C; Safar P; Bygdeman M; Gemzell-Danielsson K
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):190-5. PubMed ID: 12860340
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
8. Endometrial thickness and serum beta-hCG as predictors of the effectiveness of oral misoprostol in early pregnancy failure.
El-Baradie SMY; El-Said MH; Ragab WS; Elssery KM; Mahmoud M
J Obstet Gynaecol Can; 2008 Oct; 30(10):877-881. PubMed ID: 19038070
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
[TBL] [Abstract][Full Text] [Related]
10. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
Goldberg AB; Fulcher IR; Fortin J; Hofer RK; Cottrill A; Dethier D; Gilbert A; Janiak E; Roncari D
Obstet Gynecol; 2022 May; 139(5):771-780. PubMed ID: 35576336
[TBL] [Abstract][Full Text] [Related]
12. Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.
Wang M; Chen J; Ying J; Yu J; Huang B; Ren Z; Wang X; Guo Q; Wang Y; Qiu L; Yu H; Wan R
PLoS One; 2013; 8(5):e63755. PubMed ID: 23696855
[TBL] [Abstract][Full Text] [Related]
13. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
Roe AH; Abernathy A; Flynn AN; McAllister A; Koelper NC; Sammel MD; Schreiber CA; Sonalkar S
Obstet Gynecol; 2022 Jun; 139(6):1149-1151. PubMed ID: 35675613
[TBL] [Abstract][Full Text] [Related]
14. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
[TBL] [Abstract][Full Text] [Related]
16. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.
Hassoun D; Périn I; Hiên H; Demars HH
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():174-8. PubMed ID: 26773308
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of telephone follow-up after medical abortion.
Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
[TBL] [Abstract][Full Text] [Related]
19. Early pregnancy termination with mifepristone and misoprostol in Norway.
Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
[TBL] [Abstract][Full Text] [Related]
20. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
